From proteomics to biomarker discovery in Alzheimer's disease

Brain Research Reviews

Volumn 48, Issue 2, 2005, Pages 360-369

  Ho, Lap ^a   Sharma, Naresh ^a   Blackman, Laurel ^a   Festa, Eugene ^a   Reddy, Guru ^b   Pasinetti, Giulio Maria ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Ciphergen Biosystems   (United States)

Author keywords

Alzheimer's disease; Dementia; Proteomics

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENTARY DNA; SYNAPSIN;

ALZHEIMER DISEASE; BRAIN FUNCTION; COGNITIVE DEFECT; CONFERENCE PAPER; DEGENERATIVE DISEASE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DISEASE COURSE; DNA MICROARRAY; FEASIBILITY STUDY; GENE EXPRESSION; HIGH THROUGHPUT SCREENING; HUMAN; LENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MICROARRAY; PROTEOMICS; RISK FACTOR; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

EID: 17844407142     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresrev.2004.12.025     Document Type: Conference Paper

References (71)

1. H. Akiyama, H. Kondo, H. Mori, F. Kametani, T. Nishimura, K. Ikeda, M. Kato, and P.L. McGeer The amino-terminally truncated forms of amyloid beta-protein in brain macrophages in the ischemic lesions of Alzheimer's disease patients Neurosci. Lett. 219 1996 115 118
2. O. Alzate, S.R. Hussain, V.M. Goettl, A.K. Tewari, F. Madiai, R.L. Stephens Jr., and K.V. Hackshaw Proteomic identification of brainstem cytosolic proteins in a neuropathic pain model Brain Res., Mol. Brain Res. 128 2004 193 200
3. W. Antonin, D. Riedel, and G.F. von Mollard The SNARE Vti 1a-beta is localized to small synaptic vesicles and participates in a novel SNARE complex J. Neurosci. 20 2000 5724 5732
4. B.M. Austen, E.R. Frears, and H. Davies The use of seldi ProteinChip arrays to monitor production of Alzheimer's betaamyloid in transfected cells J. Pept. Sci. 6 2000 459 469
5. D. Beher, J.D. Wrigley, A.P. Owens, and M.S. Shearman Generation of C-terminally truncated amyloid-beta peptides is dependent on gamma-secretase activity J. Neurochem. 82 2002 563 575
6. F. Boraldi, L. Bini, S. Liberatori, A. Armini, V. Pallini, R. Tiozzo, I.P. Ronchetti, and D. Quaglino Normal human dermal fibroblasts: proteomic analysis of cell layer and culture medium Electrophoresis 24 2003 1292 1310
7. L.E. Bradbury, J.F. LeBlanc, and D.B. McCarthy ProteinChip array-based amyloid beta assays Methods Mol. Biol. 264 2004 245 257
8. D.A. Butterfield Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain Brain Res. 1000 2004 1 7
9. O. Carrette, I. Demalte, A. Scherl, O. Yalkinoglu, G. Corthals, P. Burkhard, D.F. Hochstrasser, and J.C. Sanchez A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease Proteomics 3 2003 1486 1494
10. A. Castegna, V. Thongboonkerd, J.B. Klein, B. Lynn, W.R. Markesbery, and D.A. Butterfield Proteomic identification of nitrated proteins in Alzheimer's disease brain J. Neurochem. 85 2003 1394 1401
11. T.D. Chanin, D.T. Merrick, W.A. Franklin, and F.R. Hirsch Recent developments in biomarkers for the early detection of lung cancer: perspectives based on publications 2003 to present Curr. Opin. Pulm. Med. 10 2004 242 247
12. W. Chen, J. Ji, X. Xu, S. He, and B. Ru Proteomic comparison between human young and old brains by two-dimensional gel electrophoresis and identification of proteins Int. J. Dev. Neurosci. 21 2003 209 216
13. Y.M. Cho, S.H. Bae, B.K. Choi, S.Y. Cho, C.W. Song, J.K. Yoo, and Y.K. Paik Differential expression of the liver proteome in senescence accelerated mice Proteomics 3 2003 1883 1894
14. L.H. Choe, M.J. Dutt, N. Relkin, and K.H. Lee Studies of potential cerebrospinal fluid molecular markers for Alzheimer's disease Electrophoresis 23 2002 2247 2251
15. M. Citron, D. Westaway, W. Xia, G. Carlson, T. Diehl, G. Levesque, K. Johnson-Wood, M. Lee, P. Seubert, A. Davis, D. Kholodenko, R. Motter, R. Sherrington, B. Perry, H. Yao, R. Strome, I. Lieberburg, J. Rommens, S. Kim, D. Schenk, P. Fraser, H.P. St. George, and D.J. Selkoe Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice Nat. Med. 3 1997 67 72
16. J.A. Coppinger, G. Cagney, S. Toomey, T. Kislinger, O. Belton, J.P. McRedmond, D.J. Cahill, A. Emili, D.J. Fitzgerald, and P.B. Maguire Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions Blood 103 2004 2096 2104
17. J.F. Cui, Y.K. Liu, B.S. Pan, H.Y. Song, Y. Zhang, R.X. Sun, J. Chen, J.T. Feng, Z.Y. Tang, Y.L. Yu, H.L. Shen, and P.Y. Yang Differential proteomic analysis of human hepatocellular carcinoma cell line metastasis-associated proteins J. Cancer Res. Clin. Oncol. 130 2004 615 622
18. H. Davies, L. Lomas, and B. Austen Profiling of amyloid beta peptide variants using SELDI ProteinChip arrays BioTechniques 27 1999 1258 1261
19. D.W. Dickson The pathogenesis of senile plaques J. Neuropathol. Exp. Neurol. 56 1997 321 339
20. B. Duggan, and K. Williamson Molecular markers for predicting recurrence, progression and outcomes of bladder cancer (do the poster boys need new posters?) Curr. Opin. Urol. 14 2004 277 286
21. M.C. Duran, S. Mas, J.L. Martin-Ventura, O. Meilhac, J.B. Michel, J. Gallego-Delgado, A. Lazaro, J. Tunon, J. Egido, and F. Vivanco Proteomic analysis of human vessels: application to atherosclerotic plaques Proteomics 3 2003 973 978
22. O.M. El Agnaf, D.S. Mahil, B.P. Patel, and B.M. Austen Oligomerization and toxicity of beta-amyloid-42 implicated in Alzheimer's disease Biochem. Biophys. Res. Commun. 273 2000 1003 1007
23. G. Franz, R. Beer, A. Kampfl, K. Engelhardt, E. Schmutzhard, H. Ulmer, and F. Deisenhammer Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury Neurology 60 2003 1457 1461
24. E.R. Frears, D.J. Stephens, C.E. Walters, H. Davies, and B.M. Austen The role of cholesterol in the biosynthesis of beta-amyloid NeuroReport 10 1999 1699 1705
25. E.T. Fung, G.L. Wright Jr., and E.A Dalmasso Proteomic strategies for biomarker identification: progress and challenges Curr. Opin. Mol. Ther. 2 2000 643 650
26. B.I. Giasson, V.M. Lee, and J.O. Trojanowski Interactions of amyloidogenic proteins Neuromol. Med. 4 2003 49 58
27. C. Gineste, L. Ho, P. Pompl, M. Bianchi, and G.M. Pasinetti High-throughput proteomics and protein biomarker discovery in an experimental model of inflammatory hyperalgesia: effects of nimesulide Drugs 63 Suppl. 1 2003 23 29
28. L.E. Goldstein, J.A. Muffat, R.A. Cherny, R.D. Moir, M.H. Ericsson, X. Huang, C. Mavros, J.A. Coccia, K.Y. Faget, K.A. Fitch, C.L. Masters, R.E. Tanzi, L.T. Chylack Jr., and A.I. Bush Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease Lancet 361 2003 1258 1265
29. P. Greengard, F. Valtorta, A.J. Czernik, and F. Benfenati Synaptic vesicle phosphoproteins and regulation of synaptic function Science 259 1993 780 785
30. M.B. Gretzer, D.W. Chan, C.L. van Rootselaar, J.M. Rosenzweig, S. Dalrymple, L.A. Mangold, A.W. Partin, and R.W. Veltri Proteomic analysis of dunning prostate cancer cell lines with variable metastatic potential using SELDI-TOF Prostate 60 2004 325 331
31. V. Haroutunian, D.P. Purohit, D.P. Perl, D. Marin, K. Khan, M. Lantz, K.L. Davis, and R.C. Mohs Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease Arch. Neurol. 56 1999 713 718
32. S. Hilfiker, V.A. Pieribone, A.J. Czernik, H.T. Kao, G.J. Augustine, and P. Greengard Synapsins as regulators of neurotransmitter release Philos. Trans. R. Soc. London, B Biol. Sci. 354 1999 269 279
33. L. Ho, Y. Guo, L. Spielman, O. Petrescu, V. Haroutunian, D. Purohit, A. Czernik, S. Yemul, P.S. Aisen, R. Mohs, and G.M. Pasinetti Altered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer's disease assessed by DNA microarray technique Neurosci. Lett. 298 2001 191 194
34. L. Ho, D. Purohit, V. Haroutunian, J.D. Luterman, F. Willis, J. Naslund, J.D. Buxbaum, R.C. Mohs, P.S. Aisen, and G.M. Pasinetti Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease Arch. Neurol. 58 2001 487 492
35. L. Ho, C. Gineste, P.N. Pompl, A. Dang, M. Schall, and G.M. Pasinetti Expression of Psoriasin and Cystain C in the CSF of Early Alzheimer's Disease 2nd Annual Meeting of the Society of Neuroscience Orlando, Fl (Abstr.) 2002
36. L. Ho, W. Qin, P.N. Pompl, Z. Xiang, J. Wang, Z. Zhao, Y. Peng, G. Cambareri, A. Rocher, C.V. Mobbs, P.R. Hof, and G.M. Pasinetti Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease FASEB J. 18 2004 902 904
37. S.E. Hufton, I.G. Jennings, and R.G. Cotton Structure and function of the aromatic amino acid hydroxylases Biochem. J. 311 Pt. 2 1995 353 366
38. T. Ichimura, T. Isobe, T. Okuyama, N. Takahashi, K. Araki, R. Kuwano, and Y. Takahashi Molecular cloning of cDNA coding for brain-specific 14-3-3 protein, a protein kinase-dependent activator of tyrosine and tryptophan hydroxylases Proc. Natl. Acad. Sci. U. S. A. 85 1988 7084 7088
39. C.H. Kim, D.K. Kim, S.J. Choi, K.H. Choi, K.S. Song, J. Chi, J.S. Koo, S.Y. Hwang, J.H. Yoon, and J.K. Seong Proteomic and transcriptomic analysis of interleukin-1beta treated lung carcinoma cell line Proteomics 3 2003 2454 2471
40. M.A. Korolainen, G. Goldsteins, I. Alafuzoff, J. Koistinaho, and T. Pirttila Proteomic analysis of protein oxidation in Alzheimer's disease brain Electrophoresis 23 2002 3428 3433
41. K. Kubota, K. Wakabayashi, and T. Matsuoka Proteome analysis of secreted proteins during osteoclast differentiation using two different methods: two-dimensional electrophoresis and isotope-coded affinity tags analysis with two-dimensional chromatography Proteomics 3 2003 616 626
42. X. Liu, Y. Wu, Z.E. Zehner, C. Jackson-Cook, and J.L. Ware Proteomic analysis of the tumorigenic human prostate cell line M12 after microcell-mediated transfer of chromosome 19 demonstrates reduction of vimentin Electrophoresis 24 2003 3445 3453
43. X. Luo, K.A. Carlson, V. Wojna, R. Mayo, T.M. Biskup, J. Stoner, J. Anderson, H.E. Gendelman, and L.M. Melendez Macrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment Neurology 60 2003 1931 1937
44. W. Martinet, D.M. Schrijvers, G.R. De Meyer, A.G. Herman, and M.M. Kockx Western array analysis of human atherosclerotic plaques: downregulation of apoptosis-linked gene 2 Cardiovasc. Res. 60 2003 259 267
45. E. Masliah, M. Mallory, M. Alford, R. DeTeresa, L.A. Hansen, D.W. McKeel Jr., and J.C. Morris Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease Neurology 56 2001 127 129
46. E.S. Masuda, B.C. Huang, J.M. Fisher, Y. Luo, and R.H. Scheller Tomosyn binds t-SNARE proteins via a VAMP-like coiled coil Neuron 21 1998 479 480
47. M. Mirjany, L. Ho, and G.M. Pasinetti Role of cyclooxygenase-2 in neuronal cell cycle activity and glutamate-mediated excitotoxicity J. Pharmacol. Exp. Ther. 301 2002 494 500
48. J.C. Morris Dementia update 2003 Alzheimer Dis. Assoc. Disord. 17 2003 245 258
49. R.L. Neve, R. Coopersmith, D.L. McPhie, C. Santeufemio, K.G. Pratt, C.J. Murphy, and S.D. Lynn The neuronal growth-associated protein GAP-43 interacts with rabaptin-5 and participates in endocytosis J. Neurosci. 18 1998 7757 7767
50. D.K. Ornstein, and E.F. Petricoin III Proteomics to diagnose human tumors and provide prognostic information Oncology (Huntingt) 18 2004 521 529
51. S. Parvathy, P. Davies, V. Haroutunian, D.P. Purohit, K.L. Davis, R.C. Mohs, H. Park, T.M. Moran, J.Y. Chan, and J.D. Buxbaum Correlation between Abetax-40-, Abetax-42-, and Abetax-43-containing amyloid plaques and cognitive decline Arch. Neurol. 58 2001 2025 2032
52. G.M. Pasinetti Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia J. Neurosci. Res. 65 2001 471 476
53. G.M. Pasinetti, and L. Ho From cDNA microarrays to high-throughput proteomics. Implications in the search for preventive initiatives to slow the clinical progression of Alzheimer's disease dementia Restor. Neurol. Neurosci. 18 2001 137 142
54. C.P. Paweletz, D.K. Ornstein, M.J. Roth, V.E. Bichsel, J.W. Gillespie, V.S. Calvert, C.D. Vocke, S.M. Hewitt, P.H. Duray, J. Herring, Q.H. Wang, N. Hu, W.M. Linehan, P.R. Taylor, L.A. Liotta, M.R. Emmert-Buck, and E.F. Petricoin III Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma Cancer Res. 60 2000 6293 6297
55. E.F. Petricoin, D.K. Ornstein, and L.A. Liotta Clinical proteomics: applications for prostate cancer biomarker discovery and detection Urol. Oncol. 22 2004 322 328
56. E.M. Posadas, B. Davidson, and E.C. Kohn Proteomics and ovarian cancer: implications for diagnosis and treatment: a critical review of the recent literature Curr. Opin. Oncol. 16 2004 478 484
57. M. Puchades, S.F. Hansson, C.L. Nilsson, N. Andreasen, K. Blennow, and P. Davidsson Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease Brain Res., Mol. Brain Res. 118 2003 140 146
58. A.J. Rai, and D.W. Chan Cancer proteomics: serum diagnostics for tumor marker discovery Ann. N. Y. Acad. Sci. 1022 2004 286 294
59. N.S. Schoonenboom, Y.A. Pijnenburg, C. Mulder, S.M. Rosso, E.J. Van Elk, G.J. Van Kamp, J.C. Van Swieten, and P. Scheltens Amyloid beta(1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease Neurology 62 2004 1580 1584
60. B. Seliger, R. Lichtenfels, and R. Kellner Detection of renal cell carcinoma-associated markers via proteome- and other 'ome'-based analyses Brief. Funct. Genomics Proteomics 2 2003 194 212
61. D.J. Selkoe The origins of Alzheimer disease: a is for amyloid JAMA 283 2000 1615 1617
62. M. Shoji Cerebrospinal fluid Abeta40 and Abeta42: natural course and clinical usefulness Front. Biosci. 7 2002 d997 d1006
63. R.I. Somiari, A. Sullivan, S. Russell, S. Somiari, H. Hu, R. Jordan, A. George, R. Katenhusen, A. Buchowiecka, C. Arciero, H. Brzeski, J. Hooke, and C. Shriver High-throughput proteomic analysis of human infiltrating ductal carcinoma of the breast Proteomics 3 2003 1863 1873
64. E. Storey, and R. Cappai The amyloid precursor protein of Alzheimer's disease and the Abeta peptide Neuropathol. Appl. Neurobiol. 25 1999 81 97
65. R.N. Thrift, T.M. Forte, B.E. Cahoon, and V.G. Shore Characterization of lipoproteins produced by the human liver cell line, Hep G2, under defined conditions J. Lipid Res. 27 1986 236 250
66. T. Tsuji, A. Shiozaki, R. Kohno, K. Yoshizato, and S. Shimohama Proteomic profiling and neurodegeneration in Alzheimer's disease Neurochem. Res. 27 2002 1245 1253
67. A.K. Vehmas, D.R. Borchelt, D.L. Price, D. McCarthy, M. Wills-Karp, M.J. Peper, G. Rudow, J. Luyinbazi, L.T. Siew, and J.C. Troncoso Beta-Amyloid peptide vaccination results in marked changes in serum and brain Abeta levels in APPswe/PS1DeltaE9 mice, as detected by SELDI-TOF-based ProteinChip technology DNA Cell Biol. 20 2001 713 721
68. A. Walduck, T. Rudel, and T.F. Meyer Proteomic and gene profiling approaches to study host responses to bacterial infection Curr. Opin. Microbiol. 7 2004 33 38
69. G.L. Wright Jr., M.L. Beckett, K.R. Newhall, B.L. Adam, L.H. Cazares, S.L. Cartwright, Z. Xiao, L. Gong, and P.F. Schellhammer Identification of a superimmunoglobulin gene family member overexpressed in benign prostatic hyperplasia Prostate 42 2000 230 238
70. Z. Xiang, L. Ho, S. Yemul, Z. Zhao, W. Qing, P. Pompl, K. Kelley, A. Dang, D. Teplow, and G.M. Pasinetti Cyclooxygenase-2 promotes amyloid plaque deposition in a mouse model of Alzheimer's disease neuropathology Gene Expression 10 2002 271 278
71. X. Zheng, and J.A. Bobich A sequential view of neurotransmitter release Brain Res. Bull. 47 1998 117 128